Summa Health System

Summa Health System was paid $170.73M by Medicaid between Jan 2018 and Dec 2024, across 673 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 13% of everything it billed.

33Billing provider infoSUMMA HEALTH SYSTEM
AKRON, OH 44304

33aNPI1396765681assigned 07/20/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$170.73M

24GClaims3,710,689

24DCodes billed673

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#6 of 101

Median peer was paid$22.32M

This provider vs. median7.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	314,181	$14.97M
2019	329,515	$14.73M
2020	285,099	$15.40M
2021	331,907	$15.78M
2022	473,570	$20.45M
2023	1,154,452	$52.34M
2024incomplete	821,965	$37.07M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	13%	258,588	221,277	$22.45M
96361	Intravenous infusion, hydration; each additional hour	10%	62,162	47,623	$17.89M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	10%	129,913	113,164	$17.84M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	10%	147,752	135,068	$17.45M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.9%	73,480	60,186	$11.70M
90853	Group psychotherapy (other than of a multiple-family group)	2.9%	82,003	8,590	$5.03M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.2%	14,073	10,711	$3.82M
70450	Computed tomography, head or brain; without contrast material	2.0%	13,062	10,343	$3.35M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.8%	7,332	6,181	$3.02M
G0378	Hospital observation service, per hour	1.7%	35,709	12,404	$2.92M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.6%	37,111	12,328	$2.68M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.5%	14,453	7,705	$2.48M

661 more codes

J9271	Injection, pembrolizumab, 1 mg	1.3%	228	$2.24M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.1%	10,238	$1.93M
74176	Computed tomography, abdomen and pelvis; without contrast material	1.1%	6,894	$1.90M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	10,497	$1.39M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	6,477	$1.35M
90791	Psychiatric diagnostic evaluation	<1%	6,530	$1.35M
80053	Comprehensive metabolic panel	<1%	131,471	$1.18M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,926	$1.07M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	10,720	$1.04M
47562		<1%	462	$989K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,806	$930K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	44,961	$927K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,105	$865K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	7,523	$853K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,218	$786K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	15,577	$711K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	5,993	$699K
58571		<1%	330	$698K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,853	$698K
80048	Basic metabolic panel (calcium, ionized)	<1%	95,516	$695K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	20,732	$693K
95886		<1%	1,908	$688K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	5,119	$682K
77386		<1%	1,942	$667K
95811		<1%	1,045	$632K
58661		<1%	386	$615K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	5,221	$548K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,425	$530K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	74,646	$522K
90834	Psychotherapy session, about 45 minutes	<1%	6,708	$518K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,971	$508K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,881	$502K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	93,510	$483K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	7,220	$481K
76830	Ultrasound, transvaginal	<1%	4,996	$463K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	3,057	$431K
96375	Therapeutic injection; each additional sequential IV push	<1%	52,059	$424K
64488		<1%	2,565	$415K
29848		<1%	334	$415K
96367		<1%	4,389	$397K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	10,181	$396K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	20,787	$372K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	169,887	$370K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,737	$361K
59025	Fetal non-stress test	<1%	2,459	$359K
76642		<1%	3,005	$351K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	3,049	$351K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	4,865	$350K
71045	Radiologic examination, chest; single view	<1%	46,359	$346K
70491		<1%	1,051	$327K
74240		<1%	2,112	$318K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	28,232	$312K
70496		<1%	1,282	$309K
94060		<1%	2,423	$307K
96415		<1%	1,059	$307K
84484		<1%	62,401	$304K
36415	Collection of venous blood by venipuncture	<1%	306,232	$302K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	16,867	$300K
77063	Screening digital breast tomosynthesis, bilateral	<1%	6,594	$300K
11045		<1%	968	$296K
97161		<1%	4,819	$291K
71046	Radiologic examination, chest; 2 views	<1%	13,252	$290K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	569	$288K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	11,879	$273K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,176	$270K
58558		<1%	225	$269K
76801		<1%	2,149	$258K
94760		<1%	73,301	$251K
49083		<1%	656	$247K
76819	Fetal biophysical profile; without non-stress testing	<1%	2,491	$245K
52356		<1%	119	$242K
71271		<1%	1,515	$235K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	5,686	$235K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,061	$231K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	569	$230K
71250		<1%	2,575	$230K
78815	Positron emission tomography (PET) for limited area imaging	<1%	358	$224K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	386	$221K
97162		<1%	4,198	$218K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	42,573	$210K
96146		<1%	1,648	$208K
90832	Psychotherapy session, about 30 minutes	<1%	2,307	$205K
76770		<1%	1,363	$203K
95813		<1%	253	$199K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,467	$197K
80061	Lipid panel	<1%	22,274	$197K
86850		<1%	8,655	$188K
76813		<1%	1,698	$186K
93971		<1%	2,342	$185K
85027		<1%	51,751	$184K
84443	Thyroid stimulating hormone (TSH)	<1%	18,180	$182K
93970		<1%	1,271	$182K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,055	$174K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,009	$173K
88142		<1%	9,131	$171K
81514		<1%	758	$168K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	1,418	$168K
70498		<1%	1,231	$168K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	705	$167K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	236	$165K
94727		<1%	2,499	$160K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	684	$153K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	865	$150K
87086	Culture, bacterial; quantitative colony count, urine	<1%	17,930	$150K
76536		<1%	1,485	$148K
82607		<1%	8,585	$148K
77336		<1%	1,569	$145K
88307		<1%	1,856	$142K
94729		<1%	2,693	$140K
83036	Hemoglobin; glycosylated (A1C)	<1%	26,110	$140K
95806		<1%	425	$137K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	8,289	$135K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	155	$135K
90677		<1%	940	$133K
87631		<1%	896	$132K
12001		<1%	880	$130K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,072	$129K
74183		<1%	498	$125K
19083		<1%	169	$125K
72141		<1%	737	$125K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	14,331	$123K
87102		<1%	6,150	$122K
77300		<1%	424	$119K
86900		<1%	9,599	$116K
86592		<1%	5,456	$110K
80320		<1%	5,397	$108K
82728		<1%	8,621	$107K
93017		<1%	1,108	$107K
10060		<1%	697	$103K
73630		<1%	4,217	$103K
36430		<1%	827	$103K
29580		<1%	954	$101K
93798		<1%	1,980	$96K
84630		<1%	5,211	$96K
97113		<1%	1,234	$92K
70486		<1%	1,411	$92K
93270		<1%	869	$89K
90837	Psychotherapy session, about an hour	<1%	796	$88K
86803		<1%	7,183	$87K
74174		<1%	513	$87K
Q3014	Telehealth originating site facility fee	<1%	7,797	$85K
93458		<1%	75	$85K
73221		<1%	416	$82K
73030		<1%	3,653	$81K
88341		<1%	1,217	$81K
87205		<1%	8,563	$81K
72100		<1%	2,510	$79K
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	308	$77K
J2315	Injection, naltrexone, depot form, 1 mg	<1%	66	$77K
43235		<1%	186	$77K
86361		<1%	1,837	$76K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	8,542	$76K
73560		<1%	2,071	$75K
12002		<1%	538	$75K
90670		<1%	414	$72K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	6,599	$72K
G0239	Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring)	<1%	2,247	$71K
84702		<1%	12,710	$69K
87536		<1%	1,633	$66K
90686		<1%	4,538	$66K
76870		<1%	815	$66K
97166		<1%	1,354	$65K
72158		<1%	300	$64K
83690		<1%	38,957	$64K
83735		<1%	22,797	$63K
73130		<1%	3,951	$62K
83540		<1%	8,576	$61K
77066	Tomosynthesis, mammo	<1%	1,806	$61K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	10,971	$60K
95912		<1%	651	$60K
90636		<1%	227	$60K
90715		<1%	3,855	$59K
84439		<1%	4,019	$59K
72110		<1%	1,055	$59K
90674		<1%	3,248	$58K
77334		<1%	255	$57K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	973	$56K
J9299	Injection, nivolumab, 1 mg	<1%	20	$56K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	531	$55K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	530	$55K
81001		<1%	65,190	$54K
97165		<1%	902	$53K
87340		<1%	3,942	$52K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,948	$51K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,165	$51K
74018		<1%	1,780	$50K
80076		<1%	7,495	$50K
75574		<1%	172	$50K
81025		<1%	30,905	$50K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	640	$49K
87507		<1%	495	$49K
90651		<1%	556	$48K
82746		<1%	6,209	$47K
77049		<1%	138	$47K
86762		<1%	2,463	$47K
86593		<1%	4,568	$47K
96376		<1%	11,198	$47K
77080		<1%	731	$46K
74178		<1%	194	$46K
73502		<1%	1,944	$45K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,328	$44K
77065	Tomosynthesis, mammo	<1%	1,209	$44K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	230	$43K
97116		<1%	1,591	$43K
72050		<1%	735	$43K
64418		<1%	278	$43K
94625		<1%	1,071	$42K
86140		<1%	4,778	$40K
J1756	Injection, iron sucrose, 1 mg	<1%	2,320	$40K
93880		<1%	537	$40K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,183	$40K
72040		<1%	1,132	$39K
87077		<1%	5,954	$38K
11043		<1%	187	$38K
87653		<1%	1,367	$38K
86901		<1%	9,604	$37K
73562		<1%	2,830	$37K
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	<1%	737	$37K
88342		<1%	2,891	$36K
93923		<1%	541	$36K
70544		<1%	239	$36K
82947		<1%	18,157	$36K
12011		<1%	242	$36K
73610		<1%	2,677	$36K
93225		<1%	329	$33K
76820		<1%	530	$33K
72156		<1%	171	$33K
00731		<1%	5,360	$30K
J3490	Unclassified drugs	<1%	17,231	$30K
J2791	Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu	<1%	431	$30K
95909		<1%	337	$29K
G0008	Administration of influenza virus vaccine	<1%	9,969	$29K
73565		<1%	884	$29K
82950		<1%	2,261	$29K
73564		<1%	746	$29K
84425		<1%	3,004	$28K
0352U		<1%	4,189	$27K
72131		<1%	383	$27K
90734		<1%	369	$27K
73700		<1%	237	$27K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	28,271	$27K
87522	Neg quan hep c or qual rna	<1%	836	$27K
94660		<1%	258	$26K
73110		<1%	1,859	$26K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	153	$26K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	2,701	$26K
85610		<1%	23,568	$25K
97535	Self-care/home management training, each 15 minutes	<1%	1,240	$25K
83880		<1%	6,507	$25K
70487		<1%	75	$25K
95911		<1%	435	$24K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	276	$24K
37799		<1%	26	$24K
88304		<1%	1,864	$24K
93356		<1%	1,309	$24K
77301		<1%	38	$23K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	242	$23K
72072		<1%	786	$23K
82570		<1%	4,605	$22K
92134		<1%	412	$21K
83605		<1%	8,733	$21K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	5,292	$20K
78227		<1%	79	$19K
78264		<1%	83	$19K
67028	Intravitreal injection of a pharmacologic agent	<1%	85	$19K
85055		<1%	1,960	$19K
87338		<1%	972	$19K
97035		<1%	264	$18K
87902		<1%	128	$18K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	38	$18K
83020		<1%	925	$17K
84403		<1%	973	$17K
82105		<1%	887	$17K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	190	$17K
86480		<1%	507	$17K
80069		<1%	984	$17K
93226		<1%	320	$17K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	1,666	$17K
97163		<1%	338	$17K
S9472	Cardiac rehabilitation program, non-physician provider, per diem	<1%	281	$17K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	170	$16K
81003		<1%	13,370	$16K
J1453	Injection, fosaprepitant, 1 mg	<1%	987	$15K
95012		<1%	377	$15K
86923		<1%	738	$15K
84146		<1%	1,086	$15K
36591		<1%	994	$14K
88312		<1%	784	$14K
99152		<1%	892	$14K
73080		<1%	692	$13K
93922		<1%	157	$13K
87070		<1%	2,634	$13K
72197		<1%	47	$13K
87106		<1%	1,017	$13K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	4,149	$13K
87186		<1%	4,548	$12K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	6,236	$12K
74230		<1%	108	$12K
73620		<1%	695	$12K
86706		<1%	1,390	$12K
83516		<1%	598	$12K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	147	$11K
83550		<1%	3,144	$11K
95819		<1%	82	$11K
45381		<1%	17	$11K
73120		<1%	300	$11K
86704		<1%	727	$11K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	10,613	$11K
82550		<1%	6,185	$11K
82670		<1%	335	$10K
82248		<1%	8,091	$10K
D0330	Panoramic radiographic image	<1%	366	$10K
83021		<1%	397	$10K
83615		<1%	2,418	$10K
00811		<1%	1,454	$10K
73590		<1%	1,231	$10K
J1815	Injection, insulin, per 5 units	<1%	9,023	$10K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	720	$10K
83970		<1%	489	$10K
J1170	Injection, hydromorphone, up to 4 mg	<1%	9,870	$10K
98926		<1%	233	$10K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	25	$9K
90661		<1%	1,041	$9K
26055		<1%	14	$9K
J2805	Injection, sincalide, 5 micrograms	<1%	77	$9K
85652		<1%	4,376	$9K
92083		<1%	246	$9K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	2,334	$9K
80074		<1%	836	$9K
C1776	Joint device (implantable)	<1%	347	$8K
J2704	Injection, propofol, 10 mg	<1%	28,870	$8K
72170		<1%	1,383	$8K
86038		<1%	523	$8K
96368		<1%	1,062	$8K
88112		<1%	610	$8K
82043		<1%	3,095	$8K
93242		<1%	97	$8K
90750		<1%	48	$8K
84153		<1%	717	$7K
00812		<1%	1,663	$7K
G0009	Administration of pneumococcal vaccine	<1%	1,354	$7K
82784		<1%	830	$7K
93924		<1%	69	$7K
64486		<1%	63	$7K
10061		<1%	42	$7K
74246		<1%	43	$7K
77338		<1%	42	$7K
73070		<1%	526	$7K
73552		<1%	530	$7K
71101		<1%	801	$6K
36592		<1%	977	$6K
D1110	Prophylaxis - adult	<1%	196	$6K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	12,501	$6K
73090		<1%	762	$6K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	41,171	$6K
93246		<1%	75	$6K
84156		<1%	1,562	$6K
84481		<1%	799	$6K
85014		<1%	2,532	$6K
31624		<1%	50	$6K
84100		<1%	3,344	$6K
84703		<1%	3,582	$6K
95913		<1%	63	$5K
73600		<1%	367	$5K
G0424	Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day	<1%	188	$5K
86334		<1%	311	$5K
84145		<1%	1,378	$5K
90849		<1%	112	$5K
D0140	Limited oral evaluation - problem focused	<1%	224	$5K
98927		<1%	165	$5K
87040		<1%	4,602	$5K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	879	$5K
92611		<1%	95	$5K
85379		<1%	4,636	$5K
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	5,189	$5K
Q2039	Influenza virus vaccine, not otherwise specified	<1%	974	$5K
76775		<1%	68	$5K
82565		<1%	660	$5K
87075		<1%	1,651	$4K
86431		<1%	415	$4K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	125	$4K
73140		<1%	196	$4K
99153	Mod sedat endo service >5yrs	<1%	458	$4K
00940		<1%	354	$4K
83001		<1%	234	$4K
73060		<1%	426	$4K
01810		<1%	940	$4K
29125		<1%	523	$4K
86708		<1%	358	$3K
82803		<1%	2,500	$3K
97014		<1%	73	$3K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	14	$3K
80202		<1%	516	$3K
D7140	Extraction, erupted tooth or exposed root	<1%	55	$3K
85730		<1%	3,605	$3K
93976		<1%	17	$3K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	315	$3K
96523		<1%	60	$3K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	4,182	$3K
90746		<1%	252	$3K
64445		<1%	14	$3K
85018		<1%	2,560	$3K
D0120	Dental checkup, returning patient	<1%	158	$3K
20610		<1%	17	$3K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	54,582	$3K
95816		<1%	25	$3K
Q2038	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)	<1%	859	$3K
00790		<1%	600	$3K
00910		<1%	211	$3K
D0274	Bitewings - four radiographic images	<1%	217	$3K
J9045	Injection, carboplatin, 50 mg	<1%	201	$3K
84550		<1%	685	$3K
87529		<1%	215	$3K
84165		<1%	443	$3K
90732		<1%	92	$3K
29581		<1%	40	$2K
84155		<1%	360	$2K
D0150	Comprehensive oral evaluation - new or established patient	<1%	90	$2K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	58	$2K
D0220	Intraoral - periapical first radiographic image	<1%	481	$2K
11721		<1%	52	$2K
C9113	Injection, pantoprazole sodium, per vial	<1%	1,473	$2K
88360		<1%	29	$2K
86304		<1%	147	$2K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	5,191	$2K
80164		<1%	527	$2K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	14	$2K
82330		<1%	451	$2K
72083		<1%	28	$2K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,679	$2K
88172		<1%	41	$2K
82040		<1%	719	$2K
76818		<1%	28	$2K
C1781	Mesh (implantable)	<1%	216	$2K
94664		<1%	442	$2K
84163		<1%	75	$2K
J0690	Injection, cefazolin sodium, 500 mg	<1%	4,045	$2K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,262	$2K
92610		<1%	48	$2K
82010		<1%	1,683	$2K
J1953	Injection, levetiracetam, 10 mg	<1%	186	$2K
G0390	Trauma response team associated with hospital critical care service	<1%	222	$2K
93926		<1%	16	$2K
86160		<1%	89	$2K
94010		<1%	13	$2K
00840		<1%	1,695	$1K
86200		<1%	87	$1K
96103		<1%	14	$1K
D0210	Intraoral - complete series of radiographic images	<1%	24	$1K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	14	$1K
64413		<1%	14	$1K
51701		<1%	396	$1K
73100		<1%	52	$1K
64999		<1%	12	$1K
92133		<1%	58	$1K
82533		<1%	103	$1K
C1769	Guide wire	<1%	475	$1K
80177		<1%	352	$1K
86225		<1%	80	$1K
78306		<1%	14	$1K
90648		<1%	115	$1K
84132		<1%	479	$1K
J7050	Infusion, normal saline solution, 250 cc	<1%	6,284	$1K
87493		<1%	76	$1K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	19,606	$1K
84270		<1%	70	$1K
90472	Immunization administration, each additional vaccine (list separately)	<1%	569	$967.49
94762		<1%	964	$958.54
86308		<1%	439	$945.52
89051		<1%	243	$932.33
86870		<1%	70	$929.09
00400		<1%	381	$924.37
90694		<1%	77	$912.99
88173		<1%	450	$880.81
86364		<1%	86	$880.13
86235		<1%	51	$878.86
84402		<1%	70	$872.20
J1644	Injection, heparin sodium, per 1000 units	<1%	3,359	$866.09
82140		<1%	294	$863.57
97010		<1%	21	$834.47
51702		<1%	229	$831.57
72202		<1%	12	$806.44
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	8,319	$804.45
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	6,033	$801.23
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	2,030	$783.82
97597		<1%	24	$757.95
0054A		<1%	27	$744.30
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,705	$743.76
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	15	$737.10
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	1,033	$730.47
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	794	$726.85
90656		<1%	84	$713.05
J2550	Injection, promethazine hcl, up to 50 mg	<1%	2,056	$700.35
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,236	$658.16
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	373	$625.90
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	978	$605.76
76942		<1%	126	$604.93
76098		<1%	27	$604.24
A9270	Non-covered item or service	<1%	25,173	$600.87
82378		<1%	76	$586.98
J2060	Injection, lorazepam, 2 mg	<1%	4,686	$584.46
90632		<1%	19	$573.90
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	43	$536.82
90723		<1%	104	$530.12
76937		<1%	78	$510.30
84480		<1%	144	$496.96
80323		<1%	24	$495.14
01965		<1%	110	$495.04
74022		<1%	38	$493.92
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,399	$483.27
00813		<1%	870	$482.46
86705		<1%	27	$481.48
93325		<1%	14	$476.17
85045		<1%	359	$475.30
80178		<1%	60	$469.97
72220		<1%	26	$448.44
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	652	$440.45
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	734	$431.22
87081		<1%	39	$424.08
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	4,449	$420.46
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,766	$418.38
C1760	Closure device, vascular (implantable/insertable)	<1%	445	$417.10
87449		<1%	220	$413.09
80051		<1%	119	$409.26
J0736	Injection, clindamycin phosphate, 300 mg	<1%	121	$408.00
82272		<1%	343	$392.16
87641		<1%	329	$389.51
94618		<1%	14	$388.15
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	18	$381.15
83520		<1%	13	$368.04
J1940	Injection, furosemide, up to 20 mg	<1%	1,225	$363.51
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	6,707	$358.53
90633		<1%	41	$354.60
J3411	Injection, thiamine hcl, 100 mg	<1%	578	$353.13
92015	Determination of refractive state	<1%	136	$346.85
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	49	$346.32
A9585	Injection, gadobutrol, 0.1 ml	<1%	3,881	$334.35
88302		<1%	383	$330.99
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	621	$328.74
J8540	Dexamethasone, oral, 0.25 mg	<1%	846	$318.40
84450		<1%	52	$311.95
87517		<1%	14	$309.52
83525		<1%	36	$301.16
90653		<1%	90	$292.91
96402		<1%	13	$282.84
J1630	Injection, haloperidol, up to 5 mg	<1%	1,979	$280.65
87899		<1%	235	$269.46
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	12,945	$268.42
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	788	$260.49
88313		<1%	139	$256.98
87116		<1%	162	$243.89
36416		<1%	741	$243.87
36600		<1%	42	$243.20
82652		<1%	18	$234.47
73521		<1%	13	$224.86
J7120	Ringers lactate infusion, up to 1000 cc	<1%	808	$221.16
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	667	$208.78
87206		<1%	196	$205.91
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	535	$199.02
84300		<1%	194	$197.54
A4648	Tissue marker, implantable, any type, each	<1%	462	$196.89
84460		<1%	52	$187.41
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	45	$185.34
00952		<1%	321	$178.14
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	<1%	321	$175.85
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	288	$169.33
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	572	$168.82
87076		<1%	78	$158.43
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	324	$157.50
86146		<1%	12	$152.29
J3480	Injection, potassium chloride, per 2 meq	<1%	1,241	$151.51
94761		<1%	722	$151.28
C2617	Stent, non-coronary, temporary, without delivery system	<1%	467	$147.30
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	862	$137.45
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,217	$133.95
84520		<1%	41	$133.14
80175		<1%	35	$131.48
82088		<1%	16	$127.91
A4565	Slings	<1%	694	$127.02
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	45	$126.49
91322		<1%	33	$123.06
90662		<1%	12	$118.72
82977		<1%	15	$116.07
83002		<1%	12	$101.72
88333		<1%	106	$95.28
86618		<1%	19	$91.92
29130		<1%	17	$90.63
D0230	Intraoral - periapical each additional radiographic image	<1%	22	$84.00
84436		<1%	16	$83.08
85384		<1%	20	$82.85
C1758	Catheter, ureteral	<1%	2,458	$78.28
Q9956	Injection, octafluoropropane microspheres, per ml	<1%	723	$73.25
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	121	$66.59
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	39	$65.34
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	44	$64.58
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	950	$64.55
84134		<1%	47	$62.72
J2470	Injection, pantoprazole sodium, 40 mg	<1%	328	$58.42
J1171	Injection, hydromorphone, 0.1 mg	<1%	633	$54.91
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	336	$53.55
84244		<1%	15	$50.68
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	1,889	$42.70
90480		<1%	32	$41.54
C1729	Catheter, drainage	<1%	574	$34.10
J1790	Injection, droperidol, up to 5 mg	<1%	312	$33.82
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	688	$31.74
81002		<1%	574	$31.46
G0010	Administration of hepatitis b vaccine	<1%	253	$28.54
82365		<1%	45	$20.39
Q0114	Fern test	<1%	12	$20.16
J0461	Injection, atropine sulfate, 0.01 mg	<1%	77	$19.94
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	735	$13.58
J1598	Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg	<1%	393	$11.20
J0456	Injection, azithromycin, 500 mg	<1%	36	$8.66
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	152	$7.51
J1836	Injection, metronidazole, 10 mg	<1%	60	$5.76
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	265	$5.62
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	65	$3.98
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	80	$3.10
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	64	$2.53
91305		<1%	36	$0.39
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	206	$0.00
80050	General health panel	0%	34	$0.00
C9250	Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml	0%	148	$0.00
96411		0%	318	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	638	$0.00
51798		0%	59	$0.00
80047		0%	78	$0.00
82962		0%	192	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	478	$0.00
01480		0%	137	$0.00
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	0%	24	$0.00
A9698	Non-radioactive contrast imaging material, not otherwise classified, per study	0%	112	$0.00
00142		0%	20	$0.00
84157		0%	35	$0.00
95910		0%	33	$0.00
77001		0%	12	$0.00
00160		0%	61	$0.00
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	0%	19	$0.00
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	0%	19	$0.00
31629		0%	35	$0.00
95249		0%	19	$0.00
00902		0%	30	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	14	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	31	$0.00
A9573	Injection, gadopiclenol, 1 ml	0%	42	$0.00
31654		0%	23	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	12	$0.00
69209		0%	34	$0.00
00918		0%	269	$0.00
00300		0%	172	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	275	$0.00
96417		0%	1,045	$0.00
J0670	Injection, mepivacaine hydrochloride, per 10 ml	0%	111	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	82	$0.00
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	0%	51	$0.00
00520		0%	67	$0.00
J1020	Injection, methylprednisolone acetate, 20 mg	0%	100	$0.00
01830		0%	45	$0.00
76376		0%	13	$0.00
01402		0%	30	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAHNER, DAWN (CHIEF FINANCIAL OFFICER)